公开(公告)号：US20240117045A1

公开(公告)日：2024-04-11

申请号：US18491836

申请日：2023-10-23

Applicant: INNATE PHARMA

Inventor： AGNÈS BOYER-CHAMMARD ,  PIERRE DODION ,  ROGER COHEN

IPC: C07K16/28 ,  A61P35/00 ,  C07K16/30

CPC classification number: C07K16/2803 ,  A61P35/00 ,  C07K16/2863 ,  C07K16/30 ,  A61K2039/507

Abstract: This invention relates to the use of NKG2A-targeting agents for the treatment of cancers, notably head and neck cancers, in a patient having received prior treatment with cetuximab. This invention also provides advantageous combination regimens for use with NKG2A-targeting agents for the treatment of cancers.